1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Cierpicki, T.
Otlewski, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
321
647
658
10.1016/S0022-2836(02)00620-4
12206780
NMR structures of two variants of bovine pancreatic trypsin inhibitor (BPTI) reveal unexpected influence of mutations on protein structure and stability.
2002
US
Protein Sci.
PRCIEI
0795
0961-8368
11
806
819
10.1110/ps.3510102
Analysis of serine proteinase-inhibitor interaction by alanine shaving
2002
10.2210/pdb1ld6/pdb
pdb_00001ld6
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
6211.061
PANCREATIC TRYPSIN INHIBITOR
T11A, P13A, R17A, I18A, I19A, V34A, G37A, R39A
1
man
polymer
no
no
RPDFCLEPPYAGACRAAAARYFYNAKAGLCQTFAYGACAAKRNNFKSAEDCLRTCGGA
RPDFCLEPPYAGACRAAAARYFYNAKAGLCQTFAYGACAAKRNNFKSAEDCLRTCGGA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
Escherichia
sample
9913
Bos taurus
562
Escherichia coli
BL21 (DE3) PLYSS
PLASMID
PAED4
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2002-09-11
1
1
2008-04-28
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2002-04-08
REL
REL
Structure was determined based on homonuclear TOCSY/NOESY techniques using automatic assignment in NOAH/DYANA program
structures with the lowest energy,target function
58
10
2D TOCSY
2D NOESY
DQF-COSY
0
2.9
ambient
298
K
simulated annealing, torsion angle dynamics
1
3mM BPTI_8A
90% H2O/10% D2O
Delaglio, F.; Grzesiek, S.; Vuister, G.; Zhu, G.; Pfeifer, J.; Bax, A.
processing
NMRPipe
1.8
Goddard, T.D.; Kneller, D.G.
data analysis
Sparky
3.95
Guntert, P.; Mumenthaler, C.; Herrmann, T.
structure solution
DYANA
1.5
Brunger, A.T.; Adams, P.D.; Clore, G.M.; DeLano, W.L., Gros,P.; Grosse-Kunstleve, R.W.; Jiang, J.S.; Kuszewski, J.; Nilges, M.; Pannu, N.S.; Read, R.J.; Rice, L.M.; Simonson, T.; Warren, G.L.
refinement
CNS
1.0
500
Varian
UNITYPLUS
500
Bruker
DRX
ARG
1
n
1
ARG
1
A
PRO
2
n
2
PRO
2
A
ASP
3
n
3
ASP
3
A
PHE
4
n
4
PHE
4
A
CYS
5
n
5
CYS
5
A
LEU
6
n
6
LEU
6
A
GLU
7
n
7
GLU
7
A
PRO
8
n
8
PRO
8
A
PRO
9
n
9
PRO
9
A
TYR
10
n
10
TYR
10
A
ALA
11
n
11
ALA
11
A
GLY
12
n
12
GLY
12
A
ALA
13
n
13
ALA
13
A
CYS
14
n
14
CYS
14
A
ARG
15
n
15
ARG
15
A
ALA
16
n
16
ALA
16
A
ALA
17
n
17
ALA
17
A
ALA
18
n
18
ALA
18
A
ALA
19
n
19
ALA
19
A
ARG
20
n
20
ARG
20
A
TYR
21
n
21
TYR
21
A
PHE
22
n
22
PHE
22
A
TYR
23
n
23
TYR
23
A
ASN
24
n
24
ASN
24
A
ALA
25
n
25
ALA
25
A
LYS
26
n
26
LYS
26
A
ALA
27
n
27
ALA
27
A
GLY
28
n
28
GLY
28
A
LEU
29
n
29
LEU
29
A
CYS
30
n
30
CYS
30
A
GLN
31
n
31
GLN
31
A
THR
32
n
32
THR
32
A
PHE
33
n
33
PHE
33
A
ALA
34
n
34
ALA
34
A
TYR
35
n
35
TYR
35
A
GLY
36
n
36
GLY
36
A
ALA
37
n
37
ALA
37
A
CYS
38
n
38
CYS
38
A
ALA
39
n
39
ALA
39
A
ALA
40
n
40
ALA
40
A
LYS
41
n
41
LYS
41
A
ARG
42
n
42
ARG
42
A
ASN
43
n
43
ASN
43
A
ASN
44
n
44
ASN
44
A
PHE
45
n
45
PHE
45
A
LYS
46
n
46
LYS
46
A
SER
47
n
47
SER
47
A
ALA
48
n
48
ALA
48
A
GLU
49
n
49
GLU
49
A
ASP
50
n
50
ASP
50
A
CYS
51
n
51
CYS
51
A
LEU
52
n
52
LEU
52
A
ARG
53
n
53
ARG
53
A
THR
54
n
54
THR
54
A
CYS
55
n
55
CYS
55
A
GLY
56
n
56
GLY
56
A
GLY
57
n
57
GLY
57
A
ALA
58
n
58
ALA
58
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
PHE
22
A
N
PHE
22
A
O
GLN
31
A
O
GLN
31
1
A
ALA
13
-161.89
97.96
1
A
ALA
17
-161.54
44.34
1
A
ALA
19
-79.48
45.26
1
A
ALA
27
-141.43
-1.94
1
A
THR
32
-83.23
31.80
1
A
PHE
33
65.48
159.63
1
A
TYR
35
43.75
-165.60
2
A
ALA
11
-103.97
75.13
2
A
ALA
17
-160.49
41.06
2
A
ALA
18
-175.79
80.36
2
A
ALA
19
-163.40
-55.14
2
A
PHE
33
-46.39
106.16
2
A
LYS
41
-62.90
-79.03
3
A
ARG
15
-154.48
88.41
3
A
ALA
17
-159.16
47.05
3
A
TYR
35
-64.57
65.05
3
A
LYS
41
-60.97
-77.15
4
A
PRO
9
-41.46
170.22
4
A
ALA
13
-86.67
36.00
4
A
ALA
16
64.99
95.47
4
A
ALA
17
-162.57
50.94
4
A
ALA
19
-165.00
-48.80
4
A
ALA
34
-166.07
-159.28
4
A
TYR
35
-36.91
140.86
4
A
ALA
37
-162.63
91.61
4
A
ARG
42
-84.57
-82.76
5
A
ALA
13
70.63
35.06
5
A
ALA
16
71.69
101.36
5
A
ALA
17
-163.02
44.92
5
A
ALA
19
-162.64
21.70
5
A
ALA
37
-69.74
-178.97
5
A
LYS
41
-59.77
-80.78
6
A
ARG
15
-160.44
81.53
6
A
ALA
17
71.04
62.83
6
A
ALA
19
32.42
73.41
6
A
LYS
41
91.19
-68.28
7
A
ALA
13
56.49
94.75
7
A
ALA
16
80.03
90.36
7
A
ALA
17
-160.85
64.90
7
A
ALA
19
56.59
92.13
7
A
TYR
35
-66.64
64.13
7
A
LYS
41
-63.78
-75.35
7
A
ASN
44
74.00
115.65
8
A
PRO
9
-74.94
-162.74
8
A
ALA
17
-160.60
60.33
8
A
ALA
19
-164.21
-39.67
8
A
LYS
41
-62.50
-81.24
8
A
THR
54
-80.07
-70.65
9
A
ALA
16
67.19
119.14
9
A
ALA
17
-161.78
44.70
9
A
ALA
18
-68.72
-169.25
9
A
ALA
19
47.03
25.52
9
A
TYR
35
41.56
-169.90
10
A
ALA
16
63.03
130.20
10
A
ALA
17
-161.45
45.80
10
A
ALA
18
-68.29
-174.08
10
A
ALA
34
-168.52
-152.32
10
A
TYR
35
-39.51
121.69
10
A
LYS
41
-61.16
-71.73
STRUCTURE OF BPTI_8A MUTANT
1
N
N
A
PRO
2
A
PRO
2
HELX_P
A
GLU
7
A
GLU
7
5
1
6
A
SER
47
A
SER
47
HELX_P
A
CYS
55
A
CYS
55
1
2
9
disulf
2.031
A
CYS
5
A
SG
CYS
5
1_555
A
CYS
55
A
SG
CYS
55
1_555
disulf
2.031
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.033
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
51
A
SG
CYS
51
1_555
Hydrolase Inhibitor
BPTI, Kunitz fold, Hydrolase Inhibitor
BPT1_BOVIN
UNP
1
36
P00974
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
36
93
1LD6
1
58
P00974
A
1
1
58
1
THR
engineered mutation
ALA
11
1LD6
A
P00974
UNP
46
11
1
PRO
engineered mutation
ALA
13
1LD6
A
P00974
UNP
48
13
1
LYS
conflict
ARG
15
1LD6
A
P00974
UNP
50
15
1
ARG
engineered mutation
ALA
17
1LD6
A
P00974
UNP
52
17
1
ILE
engineered mutation
ALA
18
1LD6
A
P00974
UNP
53
18
1
ILE
engineered mutation
ALA
19
1LD6
A
P00974
UNP
54
19
1
VAL
engineered mutation
ALA
34
1LD6
A
P00974
UNP
69
34
1
GLY
engineered mutation
ALA
37
1LD6
A
P00974
UNP
72
37
1
ARG
engineered mutation
ALA
39
1LD6
A
P00974
UNP
74
39
1
MET
conflict
LEU
52
1LD6
A
P00974
UNP
87
52
2
anti-parallel
A
PHE
22
A
PHE
22
A
TYR
23
A
TYR
23
A
CYS
30
A
CYS
30
A
GLN
31
A
GLN
31